Literature DB >> 15220201

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

Anthony J G Hanley1, Andreas Festa, Ralph B D'Agostino, Lynne E Wagenknecht, Peter J Savage, Russell P Tracy, Mohammed F Saad, Steven M Haffner.   

Abstract

Factor analysis, a multivariate correlation technique, has been used to provide insight into the underlying structure of the metabolic syndrome. The majority of previous factor analyses, however, have used only surrogate measures of insulin sensitivity; very few have included nontraditional cardiovascular disease (CVD) risk factors such as plasminogen activator inhibitor (PAI)-1, fibrinogen, and C-reactive protein (CRP); and only a limited number have assessed the ability of factors to predict type 2 diabetes. The objective of this study was to investigate, using factor analysis, the clustering of metabolic and inflammation variables using data from 1,087 nondiabetic participants in the Insulin Resistance Atherosclerosis Study (IRAS) and to determine the association of these clusters with risk of type 2 diabetes at follow-up. This study includes information on directly measured insulin sensitivity (S(i)) from the frequently sampled intravenous glucose tolerance test among African-American, Hispanic, and non-Hispanic white subjects aged 40-69 years. Principal factor analysis of data from nondiabetic subjects at baseline (1992-1994) identified three factors, which explained 28.4, 7.4, and 6% of the total variance in the dataset, respectively. Based on factor loadings of >or= 0.40, these factors were interpreted as 1) a "metabolic" factor, with positive loadings of BMI, waist circumference, 2-h glucose, log triglyceride, and log PAI-1 and inverse loadings of log S(i) + 1 and HDL; 2) an "inflammation" factor, with positive loadings of BMI, waist circumference, fibrinogen, and log CRP and an inverse loading of log S(i) + 1; and 3) a "blood pressure" factor, with positive loadings of systolic and diastolic blood pressure. The results were similar within strata of ethnicity, and there were only subtle differences in sex-specific analyses. In a prospective analysis, each of the factors was a significant predictor of diabetes after a median follow-up period of 5.2 years, and each factor remained significant in a multivariate model that included all three factors, although this three-factor model was not significantly more predictive than models using either impaired glucose tolerance or conventional CVD risk factors. Factor analysis identified three underlying factors among a group of inflammation and metabolic syndrome variables, with insulin sensitivity loading on both the metabolic and inflammation variable clusters. Each factor significantly predicted diabetes in multivariate analysis. The findings support the emerging hypothesis that chronic subclinical inflammation is associated with insulin resistance and comprises a component of the metabolic syndrome.

Entities:  

Mesh:

Year:  2004        PMID: 15220201     DOI: 10.2337/diabetes.53.7.1773

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  48 in total

1.  Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.

Authors:  Daniel H Solomon; Thorvardur Jon Love; Claire Canning; Sebastian Schneeweiss
Journal:  Ann Rheum Dis       Date:  2010-06-28       Impact factor: 19.103

Review 2.  Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins.

Authors:  David T Nash
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

Review 3.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 4.  Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth.

Authors:  Rebekah M Steele; Soren Brage; Kirsten Corder; Nicholas J Wareham; Ulf Ekelund
Journal:  J Appl Physiol (1985)       Date:  2008-03-27

5.  Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.

Authors:  S Shalitin; V Deutsch; R Tauman
Journal:  J Endocrinol Invest       Date:  2018-01-05       Impact factor: 4.256

Review 6.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

7.  Novel noninvasive breath test method for screening individuals at risk for diabetes.

Authors:  E Lichar Dillon; Morteza Janghorbani; James A Angel; Shanon L Casperson; James J Grady; Randall J Urban; Elena Volpi; Melinda Sheffield-Moore
Journal:  Diabetes Care       Date:  2008-12-15       Impact factor: 19.112

8.  Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population.

Authors:  Alireza Esteghamati; Ali Zandieh; Omid Khalilzadeh; Alipasha Meysamie; Haleh Ashraf
Journal:  Diabetol Metab Syndr       Date:  2010-06-08       Impact factor: 3.320

9.  Factor analysis of risk variables associated with metabolic syndrome in adult Asian Indians.

Authors:  Mithun Das; Susil Pal; Arnab Ghosh
Journal:  J Cardiovasc Dis Res       Date:  2010-04

10.  Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study.

Authors:  Louise J Maple-Brown; Joan Cunningham; Nirjhar Nandi; Allison Hodge; Kerin O'Dea
Journal:  Cardiovasc Diabetol       Date:  2010-10-29       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.